Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ugochi S. Okpechi‐Samuel"'
Autor:
Samuel O. Ajayi, Udeme E. Ekrikpo, Anyiekere M. Ekanem, Yemi R. Raji, Okechukwu S. Ogah, Dike B. Ojji, Ugochi S. Okpechi-Samuel, Kwazi C. Z. Ndlovu, Aminu K. Bello, Ikechi G. Okpechi
Publikováno v:
International Journal of Hypertension, Vol 2021 (2021)
Introduction. Hypertension is a major global cause of cardiovascular disease and death with rising worldwide prevalence, particularly in low-income countries. With low awareness, poor treatment, and low control of hypertension in Africans, there is a
Externí odkaz:
https://doaj.org/article/49db859591ae4000a95c299461a98d71
Autor:
Ikechi G. Okpechi, Vivekanand Jha, Yeoungjee Cho, Feng Ye, Chukwuonye I. Ijezie, Kailash Jindal, Scott Klarenbach, Muhammad A. Makusidi, Ugochi S. Okpechi‐Samuel, Chimezie Okwuonu, Nikhil Shah, Stephanie Thompson, Marcello Tonelli, David W. Johnson, Aminu K. Bello
Publikováno v:
Nephrology. 27:391-403
Peritoneal dialysis (PD) has several advantages compared to haemodialysis (HD), but there is evidence showing underutilization globally, especially in low-income and lower-middle-income countries (LLMICs) where kidney replacement therapies (KRT) are
Autor:
Shepherd Kajawo, Jean Jacques Noubiap, Aminu K. Bello, Andre Pascal Kengne, Mohamed A. Osman, Ikechi G. Okpechi, Mothusi Walter Moloi, Udeme E. Ekrikpo, Ugochi S. Okpechi-Samuel
Publikováno v:
Kidney International Reports
Introduction Kidney biopsy is an important tool for making diagnoses and for assessing the drug treatment requirements and disease prognosis in the management of kidney diseases. There are variations in the rate of complications associated with kidne
Autor:
Ugochi S. Okpechi-Samuel, Ayanda Gcelu, Udeme E. Ekrikpo, T I Umeizudike, Bianca Davidson, Innocent Ijezie Chukwuonye, Ikechi G. Okpechi, Phelisa Sogayise, Nicola Wearne
Publikováno v:
International Journal of Nephrology
International Journal of Nephrology, Vol 2020 (2020)
International Journal of Nephrology, Vol 2020 (2020)
Background. Lupus nephritis (LN) can be complicated with requirement for kidney replacement therapy and death. Efficacy of induction therapies using mycophenolate mofetil (MMF) or intravenous cyclophosphamide (IVCYC) has been reported from studies, b
Autor:
Ugochi S. Okpechi-Samuel, Pierre Ronco, Nicola Wearne, Ikechi G. Okpechi, Aminu K. Bello, Francois Cj Botha, Oluwatoyin I. Ameh, Bingileki F Lwezaula, Udeme E. Ekrikpo
Publikováno v:
BMC Nephrology
BMC Nephrology, Vol 22, Iss 1, Pp 1-8 (2021)
BMC Nephrology, Vol 22, Iss 1, Pp 1-8 (2021)
Background: Serum and tissue-based tests using phospholipase A2 receptor 1 (PLA2R) and thrombospondin type-1 domain containing 7A (THSD7A) are established immune biomarkers for the diagnosis of primary membranous nephropathy (PMN). This study assesse
Autor:
Mothusi Walter Moloi, Udeme E. Ekrikpo, Ikechi G. Okpechi, Ugochi S. Okpechi-Samuel, Aminu K. Bello, Jean Jacques Noubiap
Publikováno v:
BMJ Open
BMJ Open, Vol 10, Iss 12 (2020)
BMJ Open, Vol 10, Iss 12 (2020)
ObjectiveThe aim of this study was to report the prevalence of peritonitis and mortality in patients with end-stage kidney disease (ESKD) treated with chronic peritoneal dialysis (PD) in Africa.DesignSystematic review.SettingAfrica.ParticipantsPatien
Autor:
Bingileki F Lwezaula, Oluwatoyin I Ameh, Udeme E Ekrikpo, Francois CJ Botha, Ugochi S Okpechi-Samuel, Nicola Wearne, Pierre Ronco, Aminu K Bello, Ikechi G. Okpechi
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-8 (2021)
Abstract Background: Serum and tissue-based tests using phospholipase A2 receptor 1 (PLA2R) and thrombospondin type-1 domain containing 7A (THSD7A) are established immune biomarkers for the diagnosis of primary membranous nephropathy (PMN). This stud
Externí odkaz:
https://doaj.org/article/41a87cfa91a64dc4b964a250e88d6db6
Autor:
Jean Jacques Noubiap, Aminu K Bello, Ikechi G Okpechi, Udeme Ekrikpo, Mothusi W Moloi, Ugochi S Okpechi-Samuel
Publikováno v:
BMJ Open, Vol 10, Iss 12 (2020)
Objective The aim of this study was to report the prevalence of peritonitis and mortality in patients with end-stage kidney disease (ESKD) treated with chronic peritoneal dialysis (PD) in Africa.Design Systematic review.Setting Africa.Participants Pa
Externí odkaz:
https://doaj.org/article/31890189fd9a4c829cde00d3b7fa4cef